Search
SOLACI Congress
HomeInternational CongressesTCT 2013.

TCT 2013.

View Category
Day 3

OPTIMIZE: 3 versus 12 months dual antiplatelet therapy after angioplasty with DES

Currently the recommendation is 12 months of dual antiplatelet after a drug-eluting stent angioplasty. This study compared...
solaci -
Learn More
Day 2

HeartFlowNXT: Using noninvasive FFR shows promising results

The use of fractional flow reserve (FFR) is useful to determine the significance of coronary lesions. The...
solaci -
Learn More
Day 2

Exclusive Interview with Dr. Henrique Ribeiro on his article: coronary obstruction after TAVI

Recentemente uma revisão e metanálise sobre obstrução coronária após o implante de TAVI foi publicada na revista...
solaci -
Learn More
Day 2

LEVANT 2: Initial results from the new drug eluting balloon for femoropopliteal lesions

This prospective multicenter study randomized 476 patients 2:1 to paclitaxel eluting balloon versus conventional balloon for femoropopliteal...
solaci -
Learn More
Day 2

RIBS V: Pharmacological balloon vs second-generation drug-eluting stent in the treatment of BMS restenosis

The ideal therapy for treating in-stent restenosis continues to be debated . The pharmacological balloons showed good...
solaci -
Learn More
Day 2

SMART-CASE: Angiographic Guidanceangioplastyto >50% versus >70% lesions.

This prospective randomized study compared aggressive revascularization angiography injuries 50% versus a most conservative revascularization lesions>70%.The primary...
solaci -
Learn More
Day 2

CHILL-MI: Hypothermia fails to show benefit in patients with acute ST- elevation IAM.

Hypothermia improves myocardial ischemia in animals but studies in humans failed to demonstrate benefit to that extent.We...
solaci -
Learn More
Day 2

ADVISE II: iFFR comparable toFFRbut with out adenosine

Several studies tested the utility of fractional flow reserve (FFR) to assess coronary lesions functionally. The FFR...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy